Home
About Us
Journal Overview Aims And Scope Editorial Board Permissions Copyright
Current Archive
Submission Guidelines
Editorial Policy
Peer Review Reviewer Responsibilities Scientific Integrity Retraction Policy Disclaimer
News Contact
×
Home

Journal Overview Aims And Scope Editorial Board Permissions Copyright
Current Archive Submission Guidelines

Peer Review Reviewer Responsibilities Scientific Integrity Retraction Policy Disclaimer
News Contact
Research paper
Published: 01.12.2023.
<< Prev | Next >>
PDF
https://doi.org/10.5937/afmnai41-43726

A co-infection of primary varicella and COVID-19: A case report

By
Irfan Ćorović ,
Irfan Ćorović

University of Kragujevac , Kragujevac , Serbia

View authors publications

Search this author on:

PubMed | Google Scholar
Emina Ćorović-Ličina ,
Emina Ćorović-Ličina
View authors publications

Search this author on:

PubMed | Google Scholar
Bojana Simović-Marković Orcid logo ,
Bojana Simović-Marković

University of Kragujevac , Kragujevac , Serbia

View authors publications

Search this author on:

PubMed | Google Scholar
Selma Habibović ,
Selma Habibović
View authors publications

Search this author on:

PubMed | Google Scholar
Ahmo Habibović ,
Ahmo Habibović
View authors publications

Search this author on:

PubMed | Google Scholar
Samir Vučelj ,
Samir Vučelj
View authors publications

Search this author on:

PubMed | Google Scholar
Lejla Ćeranić
Lejla Ćeranić
View authors publications

Search this author on:

PubMed | Google Scholar

Abstract

Introduction. Primary varicella usually occurs in childhood and is generally self-limiting. In adults and immunocompromised individuals, it can have a more serious course. Obesity is one of the risk factors for a severe COVID-19 infection that can lead to immunosuppression among other systemic complications. This case report aims to present a rare co-infection of varicella-zoster virus and SARS-CoV-2 in an adult, as well as to evaluate the impact of this co-infection on the progression and severity of both diseases in order to highlight the significance of antiviral therapy in treating both infections. Case report. We report a case of a 34-year-old obese woman with varicella-zoster virus and SARS-CoV-2 co-infection who was successfully treated with oral acyclovir and nirmatrelvir-ritonavir without developing significant complications. Conclusion. Currently, there is not enough evidence to claim that co-infection with varicella-zoster virus and SARS-CoV-2 increases the chances of a more severe form of either of these infections. With effective antiviral therapy, it is possible to significantly reduce the chances of developing more severe forms of both infections, which physicians need to be aware of in case they come across it and respond promptly.

References

1.
Gershon AA, Breuer J, Cohen JI, Cohrs RJ, Gershon MD, Gilden D, et al. Varicella zoster virus infection. Nature Reviews Disease Primers. 1(1).

Citation

Copyright

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

Article metrics

Google scholar: See link
Issue image
Vol 41, Issue 2, 2024
Improving estimate of cost/effectiveness of drugs for rare diseases Skin challenges in COVID-19 pandemic: The importance of cosmeceuticals The influence of psychoactive substances on nephrotoxicity of the kidneys Care needs of patients with heart failure: A systematic review Non-factor replacement therapy: A new chapter in hemophilia a prophylaxis See full issue
Widget Side

The statements, opinions and data contained in the journal are solely those of the individual authors and contributors and not of the publisher and the editor(s). We stay neutral with regard to jurisdictional claims in published maps and institutional affiliations.